Chemomab Therapeutics

(NASDAQ) CMMB

Current Price$1.77

Market Cap$12.87M

Since IPO (2021)-99%

5 Year-98%

1 Year-63%

1 Month+8%

Chemomab Therapeutics Financials at a Glance

Market Cap

$12.87M

Revenue (TTM)

$0.00

Net Income (TTM)

$9.01M

EPS (TTM)

$-1.47

P/E Ratio

-1.22

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Price

$1.77

Volume

Open

$1.80

Price

$1.77

Volume

Open

$1.80

Previous Close

$1.77

Daily Range

$1.77 - $1.80

52-Week Range

$1.35 - $5.88

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Price

$1.77

Volume

Open

$1.80

Previous Close

$1.77

Daily Range

$1.77 - $1.80

52-Week Range

$1.35 - $5.88

CMMB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Chemomab Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Adi Mor, PhD

Website

www.chemomab.com

Headquarters

Tel Aviv, 6158002, IL

CMMB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-70%

Return on Capital

-78%

Return on Assets

-65%

Earnings Yield

-81.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.87M

Shares Outstanding

7.19M

Volume

Avg. Volume

67.08K

Financials (TTM)

Gross Profit

$70.56K

Operating Income

$9.64M

EBITDA

$9.57M

Operating Cash Flow

$11.22M

Capital Expenditure

$3.03K

Free Cash Flow

$11.22M

Cash & ST Invst.

$10.37M

Total Debt

$0.00

Chemomab Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$12.87M

N/A

Market Cap/Employee

$643.71K

N/A

Employees

N/A

Net Income

$1.88M

+36.4%

EBITDA

$1.97M

+38.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$10.37M

-25.7%

Accounts Receivable

$3.06M

+1063.1%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-65.21%

N/A

Return on Invested Capital

-77.67%

N/A

Free Cash Flow

$11.22M

N/A

Operating Cash Flow

$11.22M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BIVIBioVie Inc.

BIVIBioVie Inc.$1.54-7.23%

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$2.16+1.41%

KZIAKazia Therapeutics Limited

KZIAKazia Therapeutics Limited$13.41-3.11%

GLMDGalmed Pharmaceuticals Ltd.

GLMDGalmed Pharmaceuticals Ltd.$0.63-0.22%

INMInMed Pharmaceuticals Inc.

INMInMed Pharmaceuticals Inc.$0.70-4.13%

XRTXXORTX Therapeutics Inc.

XRTXXORTX Therapeutics Inc.$2.65-3.99%

CEROCERo Therapeutics Holdings, Inc.

CEROCERo Therapeutics Holdings, Inc.$0.03-10.68%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.73+0.00%

ACHRArcher Aviation

ACHRArcher Aviation$6.28-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.00-0.02%

Questions About CMMB

What is the current price of Chemomab Therapeutics?

Chemomab Therapeutics is trading at $1.77 per share.

What is the 52-week range for Chemomab Therapeutics?

Over the past 52 weeks, Chemomab Therapeutics has traded between $1.35 and $5.88.

How much debt does Chemomab Therapeutics have?

As of the most recent reporting period, Chemomab Therapeutics reported total debt of N/A.

How much cash does Chemomab Therapeutics have on hand?

Chemomab Therapeutics reported $7.56M in cash and cash equivalents in its most recent financial results.

What is Chemomab Therapeutics’s dividend yield?

Chemomab Therapeutics does not currently have a dividend yield.

Chemomab Therapeutics

Chemomab Therapeutics Financials at a Glance

CMMB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Chemomab Therapeutics

CMMB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Chemomab Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CMMB

What is the current price of Chemomab Therapeutics?

What is the 52-week range for Chemomab Therapeutics?

How much debt does Chemomab Therapeutics have?

How much cash does Chemomab Therapeutics have on hand?

What is Chemomab Therapeutics’s dividend yield?

Premium Investing Services